Journal Report

Surgical Oncology

Download PDF
Journal Information
Journal Title
Surgical Oncology
Publisher
Elsevier Ltd
ISSN
0960-7404
E-ISSN
1879-3320
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Association between nerve-sparing techniques and oncologic outcomes following radical prostatectomy: A multi-institutional analysis from the Medical Investigation Cancer Network (MICAN) study
Katsuyoshi Hashine, Noriyoshi Miura, Hirofumi Sogabe et al.
2027-2 Vol. 70 Pages 102589
DOI: 10.1016/j.suronc.2026.102589
Neoadjuvant chemotherapy and mesh assistance in immediate DTI subpectoral breast reconstruction: PROs and surgical complications
Peng Gao, Hongchuan Jiang, Xiangyi Kong et al.
2027-2 Vol. 70 Pages 102591
DOI: 10.1016/j.suronc.2026.102591
Prognostic heterogeneity and risk stratification in surgically treated borderline resectable 2 hepatocellular carcinoma
Shinichi Ikuta, Tsukasa Aihara, Takayoshi Nakajima et al.
2027-2 Vol. 70 Pages 102598
DOI: 10.1016/j.suronc.2026.102598
Survival benefit of prophylactic central neck dissection in T3b differentiated thyroid carcinoma
Yunzhe Zhao, Chao Long, Lei Xiao
2027-2 Vol. 70 Pages 102599
DOI: 10.1016/j.suronc.2026.102599
Survival impact of completing adjuvant chemotherapy after neoadjuvant chemoradiotherapy and curative-intent resection for localized pancreatic ductal adenocarcinoma
Yasuhiro Murata, Yuki Segi, Haruna Komatsubara et al.
2027-2 Vol. 70 Pages 102590
DOI: 10.1016/j.suronc.2026.102590
Corrigendum to ‘Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis of long-term outcomes’ [Surg. Oncol. 67, (2026), 102494]
Sang-ji Choi, Gibong Chae
2027-2 Vol. 70 Pages 102603
DOI: 10.1016/j.suronc.2026.102603
Lenvatinib vs sorafenib as second-line therapy after ATE+BEV failure in advanced hepatocellular carcinoma: A meta-analysis
Yongqi Li, Xu Geng, Liulan Qian et al.
2027-2 Vol. 70 Pages 102600
DOI: 10.1016/j.suronc.2026.102600
International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot
Chiara D'Alterio, Quirino Lai, Maria Lanzone et al.
2026-12 Vol. 69 Pages 102580
DOI: 10.1016/j.suronc.2026.102580
Metachronous contralateral papillary thyroid carcinoma following lobectomy: Incidence, clinicopathological shifts, and survival outcomes in a population-based cohort
Shangcheng Yan, Keyu Shen, Zhen Cao et al.
2026-12 Vol. 69 Pages 102588
DOI: 10.1016/j.suronc.2026.102588
The VITAL prognostic model for cHCC-CCA after surgery: Integrating viral, inflammatory, tumor biology, and anatomic lesion
Xiwen Yang, Jiang Zhu
2026-12 Vol. 69 Pages 102577
DOI: 10.1016/j.suronc.2026.102577
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 9, 2026 14:28